Article
Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice.
Genes, brain, and behavior - 1 Feb 2010
Labrie V, Wang W, Barger S W, Baker G B, Roder J C
Abstract excerpt
Reduced function of the N-methyl-d-aspartate receptor (NMDAR) has been implicated in the pathophysiology of schizophrenia. The NMDAR contains a glycine binding site in its NR1 subunit that may be a useful target for the treatment of schizophrenia. In this study, we assessed the therapeutic potential of long-term increases in the brain levels of the endogenous NMDAR glycine site agonist D-serine, through the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
